Value
8.4/10data confidence 83%| Component | Sub-score |
|---|---|
| P/S | 10.0 |
| EV/EBITDA | 5.0 |
| Fwd P/E | 9.5 |
| PEG | 10.0 |
| Analyst target | 7.5 |
- ▸Forward P/E: 8.4x
- ▸PEG: 0.05
- ▸Attractively valued
CC · Why this verdict
Why Chemours Company (The) (CC) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score5.4/10
ConfidenceMEDIUM
MacroNEUTRAL
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
A forward price-to-earnings multiple of 9.9 times and a near-zero price-to-earnings-to-growth ratio appear attractive in isolation, but with a quality score below the minimum investable threshold and near-zero profitability, the low multiple most likely reflects a risk premium rather than genuine mispricing. Valuation breakdown | The valuation case becomes credible when the quality score rises above 4.0 for 2 consecutive quarters, confirming that the earnings recovery is durable enough to justify owning the multiple. | →Stable |
| CounterExtremely low price-to-earnings-to-growth ratios can occasionally signal inflection points where the market has overcorrected downward; if end-market pricing turns favorable and margins recover rapidly, the stock could re-rate sharply from depressed levels. | ||
With a quality score of 2.4 — well below the minimum threshold of 4.0 — and no identifiable competitive moat, near-zero net margin, and return on equity at essentially zero, the underlying business lacks the financial strength that would justify holding through a difficult environment. Quality breakdown | The quality profile recovers when net margin rises above 5% for 2 consecutive quarters, demonstrating that the business can generate durable returns. | →Stable |
| CounterA very low Piotroski financial health score would amplify concerns, but the score here is 6.7 out of 9, suggesting balance-sheet mechanics remain intact; the quality failure is in profitability, not solvency, and profitability can recover faster if pricing improves. | ||
Three of the last four quarters technically beat consensus, but the two most recent beats involved triple-digit percentage surprises against estimates of negative $0.04 and positive $0.02 respectively — actual earnings in both cases were only $0.05 per share, which represents a collapsed earnings base rather than genuine outperformance. Earnings | The beat pattern gains credibility when actual EPS exceeds $0.20 per share for 2 consecutive quarters, demonstrating recovery beyond the current near-zero base. | →Stable |
| CounterThe fact that the company can beat even minimal estimates signals that the deterioration may have found a floor; if the business stabilizes at $0.05 EPS per quarter while guidance is set conservatively, the beat streak could persist and attract value-oriented attention. | ||
The high dividend yield has been flagged as potentially uncovered, suggesting the payout may not be fully supported by free cash flow and that income-seeking holders face a meaningful risk of a dividend reduction. Catalyst breakdown | Dividend safety concerns are resolved when operating margin rises above 5% for 2 consecutive quarters, generating cash flow sufficient to cover the declared dividend. | →Stable |
| CounterCompanies in cyclical speciality chemicals can sustain high payouts through a trough by drawing on balance-sheet capacity; if the current weakness is cyclical rather than structural, the dividend could be maintained without a cut while the business recovers. | ||
A C-suite officer departure or appointment has been flagged, adding a layer of operational uncertainty to an already-challenged quality and profitability profile at a sensitive point in the company's recovery. Gates warning | Management continuity concerns dissipate when 0 additional C-suite officer departures or appointments are flagged over the next 4 consecutive quarters, indicating leadership stability has been restored. | →Stable |
| CounterA single executive change does not necessarily destabilize a large organization; if the appointment brings relevant industry experience, it could prove a catalyst for operational improvement rather than a distraction. | ||
A forward price-to-earnings multiple of 9.9 times and a near-zero price-to-earnings-to-growth ratio appear attractive in isolation, but with a quality score below the minimum investable threshold and near-zero profitability, the low multiple most likely reflects a risk premium rather than genuine mispricing.
→StableValuation breakdown
- Expectation
- The valuation case becomes credible when the quality score rises above 4.0 for 2 consecutive quarters, confirming that the earnings recovery is durable enough to justify owning the multiple.
CounterExtremely low price-to-earnings-to-growth ratios can occasionally signal inflection points where the market has overcorrected downward; if end-market pricing turns favorable and margins recover rapidly, the stock could re-rate sharply from depressed levels.
With a quality score of 2.4 — well below the minimum threshold of 4.0 — and no identifiable competitive moat, near-zero net margin, and return on equity at essentially zero, the underlying business lacks the financial strength that would justify holding through a difficult environment.
→StableQuality breakdown
- Expectation
- The quality profile recovers when net margin rises above 5% for 2 consecutive quarters, demonstrating that the business can generate durable returns.
CounterA very low Piotroski financial health score would amplify concerns, but the score here is 6.7 out of 9, suggesting balance-sheet mechanics remain intact; the quality failure is in profitability, not solvency, and profitability can recover faster if pricing improves.
Three of the last four quarters technically beat consensus, but the two most recent beats involved triple-digit percentage surprises against estimates of negative $0.04 and positive $0.02 respectively — actual earnings in both cases were only $0.05 per share, which represents a collapsed earnings base rather than genuine outperformance.
→StableEarnings
- Expectation
- The beat pattern gains credibility when actual EPS exceeds $0.20 per share for 2 consecutive quarters, demonstrating recovery beyond the current near-zero base.
CounterThe fact that the company can beat even minimal estimates signals that the deterioration may have found a floor; if the business stabilizes at $0.05 EPS per quarter while guidance is set conservatively, the beat streak could persist and attract value-oriented attention.
The high dividend yield has been flagged as potentially uncovered, suggesting the payout may not be fully supported by free cash flow and that income-seeking holders face a meaningful risk of a dividend reduction.
→StableCatalyst breakdown
- Expectation
- Dividend safety concerns are resolved when operating margin rises above 5% for 2 consecutive quarters, generating cash flow sufficient to cover the declared dividend.
CounterCompanies in cyclical speciality chemicals can sustain high payouts through a trough by drawing on balance-sheet capacity; if the current weakness is cyclical rather than structural, the dividend could be maintained without a cut while the business recovers.
A C-suite officer departure or appointment has been flagged, adding a layer of operational uncertainty to an already-challenged quality and profitability profile at a sensitive point in the company's recovery.
→StableGates warning
- Expectation
- Management continuity concerns dissipate when 0 additional C-suite officer departures or appointments are flagged over the next 4 consecutive quarters, indicating leadership stability has been restored.
CounterA single executive change does not necessarily destabilize a large organization; if the appointment brings relevant industry experience, it could prove a catalyst for operational improvement rather than a distraction.
TrendMatrix Research · core thesis
Engine thesis — one sentence
Chemours trades at an apparent valuation discount, but that cheapness functions as a risk premium — business quality has collapsed well below the minimum investable threshold, margins are near zero, and the dividend yield appears uncovered; the balance of evidence points toward exiting rather than holding this position.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Per-dimension breakdown
Quality
2.4/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 0.0 |
| ROA | 1.4 |
| Gross margin | 0.0 |
| Op margin | 1.2 |
| Net margin | 0.0 |
| Current ratio | 6.5 |
| Moat | 3.1 |
| Piotroski F | 6.7 |
- ▸No competitive moat
- ▸Quality concerns
Growth
6.3/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 2.7 |
| EPS growth | 10.0 |
Momentum
3.6/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 8.0 |
| MACD | 1.3 |
| OBV | 1.0 |
| MA position | 4.0 |
| Volume | 3.6 |
- ▸Uptrend pullback (RSI 35) - buy opportunity
- ▸Volume distribution (falling OBV)
- ▸Above 200-day MA
Sentiment
7.8/10data confidence 100%| Component | Sub-score |
|---|---|
| LLM sentiment | 7.8 |
| Analyst rating | 6.9 |
| Price target | 8.8 |
- ▸LLM news sentiment: +0.55 (n=1)
- ▸Light analyst coverage (9.0) — signal dampened
- ▸Analyst upside: 34%
Insider
5.0/10data confidence 50%| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 5.1 |
- ▸No net insider activity — $0 (0.000% of mkt cap)
Peer rank
3.1/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 8.7 |
| quality rank | 0.8 |
| growth rank | 3.0 |
Technical
7.2/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 10.0 |
| support resistance | 9.5 |
| 52w position | 3.3 |
| gap | 6.0 |
Risk (lower is worse)
3.9/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 5.3 |
| days to cover | 6.1 |
| volatility | 0.0 |
| put call | 10.0 |
| implied vol | 0.4 |
| beta | 5.4 |
| debt equity | 0.0 |
- ▸High IV: 78%
Catalyst
5.9/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 6.7 |
| earnings timing | 5.0 |
| surprise avg | 10.0 |
| dividend safety | 3.5 |
| news activity | 5.0 |
- ▸Strong earnings: 3B/1M
- ▸Yield trap warning: high yield but unsafe
How the verdict was assembled
Engine trigger
Quality below minimum threshold.
Engine technical detail
verdict_path:
L1:HARD_BLOCKPassed (5)
- INSIDER:OK
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:31d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (2)
- MOMENTUM:3.6<4.5
- ASYMMETRY:1.2<1.5@spot
Warning (1)
- 8K_CSUITE_CHANGE:5.02 (officer departure/appointment)
Reward-to-Risk
1.17
Upside
+16.4%
Downside
14.0%
Sizing output
AVOID
Setup— — No clear chart pattern; technical signals are mixed
EdgeNo clear edge — No clear edge identified
SuitabilityAggressive — Beta 1.40>1.3, MCap $2.9B<$5B
Investment implication
The L1 gate blocked the positive-verdict path: a hard-floor threshold was breached, so dimensional pillars — including Value at 8.4 could not lift the engine output above the verdict floor. Failed gate signal: MOMENTUM:3.6<4.5.
The strongest dimensions are Value at 8.4, Sentiment at 7.8, and Technical at 7.2; the weakest are Quality at 2.4, Peer rank at 3.1, and Momentum at 3.6. The V9 engine flagged 2 failed gates with 1 warning, producing an asymmetric reward-to-risk of 1.17 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Quality Below Investable Floor
Trip ifNet margin rises above 5% for 2 consecutive quarters from the current near-zero level.
- P2Beats On Near Zero Earnings Base
Trip ifActual EPS exceeds $0.20 per share for 2 consecutive quarters.
- P3Dividend Yield Trap
Trip ifOperating margin rises above 5% for 2 consecutive quarters, generating cash flow to cover the dividend.
- P4Valuation Discount Masks Earnings Risk
Trip ifQuality score rises above 4.0 for 2 consecutive quarters, indicating a durable earnings recovery.
- P5Management Continuity Concern
Trip ifFewer than 1 additional C-suite officer departures or appointments are disclosed in regulatory filings over the next 4 consecutive quarters, indicating management has stabilized.